| abstract |
A phenoxypyridine derivative having a chemical structure represented by the following general formula (I) and having a Na + / Ca2 + exchanger inhibitory action selective against reverse mode, or a pharmaceutically acceptable salt thereof, and this as an active ingredient The present invention relates to a therapeutic drug for kidney disease and cardiovascular disease. (Where Ar: phenyl or thienyl, -A-: -NHCO-B- or -BNHCO- -B-: single bond or alkylene Pyr: optionally substituted pyridyl R1 and R2: the same or different, lower alkyl optionally substituted with one or more halogen, halogen or hydrogen atom n: 0-4 Integer m: an integer from 0 to 3. ) |